UA98605C2 - Новый способ предотвращения или лечения инфекции m. tuberculosis - Google Patents
Новый способ предотвращения или лечения инфекции m. tuberculosisInfo
- Publication number
- UA98605C2 UA98605C2 UAA200711587A UAA200711587A UA98605C2 UA 98605 C2 UA98605 C2 UA 98605C2 UA A200711587 A UAA200711587 A UA A200711587A UA A200711587 A UAA200711587 A UA A200711587A UA 98605 C2 UA98605 C2 UA 98605C2
- Authority
- UA
- Ukraine
- Prior art keywords
- tuberculosis infection
- fusion protein
- preventing
- treating
- mtb72f
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Abstract
Изобретение относится к способам предотвращения реактивации активной или латентной инфекций М. tuberculosis путем введения фармацевтической композиции, которая включает нуклеиновую кислоту, которая кодирует Mtb72f слитый белок, или Mtb72f слитый белок, или его иммуногенный фрагмент, например, вместе с адьювантом. Mtb72f нуклеиновая кислота или слитый белок могут вводиться с одним или более из химиотерапевтических агентов, эффективных против инфекции М. tuberculosis. Способы также обеспечивают сокращение времени курса химиотерапевтического режима против инфекции М. tuberculosis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67654905P | 2005-04-29 | 2005-04-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA98605C2 true UA98605C2 (ru) | 2012-06-11 |
Family
ID=40006338
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201111598A UA107788C2 (en) | 2005-04-29 | 2006-04-27 | A fusion protein of m. tuberculosis |
UAA200711587A UA98605C2 (ru) | 2005-04-29 | 2006-04-27 | Новый способ предотвращения или лечения инфекции m. tuberculosis |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201111598A UA107788C2 (en) | 2005-04-29 | 2006-04-27 | A fusion protein of m. tuberculosis |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN105903008B (ru) |
UA (2) | UA107788C2 (ru) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2374620T3 (es) * | 2000-06-20 | 2012-02-20 | Corixa Corporation | Antígeno mtb32a de mycobacterium tuberculosis con el sitio activo inactivado y proteínas de fusión de los mismos. |
US20030175294A1 (en) * | 2001-03-13 | 2003-09-18 | Corixa Corporation | Heterologous fusion protein constructs comprising a Leishmania antigen |
AU2003213118A1 (en) * | 2002-02-15 | 2003-09-09 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
-
2006
- 2006-04-27 CN CN201610086198.9A patent/CN105903008B/zh not_active Expired - Fee Related
- 2006-04-27 UA UAA201111598A patent/UA107788C2/ru unknown
- 2006-04-27 UA UAA200711587A patent/UA98605C2/ru unknown
Also Published As
Publication number | Publication date |
---|---|
CN105903008B (zh) | 2020-01-03 |
CN105903008A (zh) | 2016-08-31 |
UA107788C2 (en) | 2015-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12013502449A1 (en) | Novel method for preventing or treating m tuberculosis infection | |
CY1110886T1 (el) | Συνθεσεις για την καταπολεμηση της αντοχης στα αντιβιοτικα με μεσολαβηση β-λακταμασης, χρησιμοποιωντας αναστολεις β-λακταμασης χρησιμους για ενεση | |
MY141025A (en) | Dose forms | |
CO5700796A2 (es) | Composiciones que contienen piperacilina y tazobactam utiles para inyecciones | |
NO20071711L (no) | Sammensetninger inneholdende piperacillin, tazobactam og en aminokarboksylsyre i et natriumlaktat fortynningsmiddel | |
UA99094C2 (ru) | Способ лечения пациента с системной красной волчанкой | |
BRPI0415953B8 (pt) | formulação de dosagem de liberação controlada e conjunto de formas de dosagem de liberação controlada | |
PE20190351A1 (es) | Agente terapeutico del sindrome de hunter y metodo de tratamiento | |
EA200501821A1 (ru) | Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат | |
WO2005030109A3 (en) | Regimen for the administration of rifamycin-class antibiotics | |
ECSP044985A (es) | Azitromicina de dosis única para infecciones respiratorias | |
UA98605C2 (ru) | Новый способ предотвращения или лечения инфекции m. tuberculosis | |
CY1115823T1 (el) | Νεα μεθοδος προληψης ή θεραπειας μολυνσης m. tuberculosis | |
BR0307196A (pt) | Idraparinux (sanorg 34006) para tratamento e profilaxia secundária de eventos tromboembólicos venosos em pacientes com trombose venosa profunda | |
TH1701007800A (th) | ตัวยับยั้งเมทัลโล-บีตา-แลคทาเมส | |
DK1677808T3 (da) | Kombinationspræparat til behanding af sepsis | |
WO2015027040A3 (en) | Methods and compositions for treating schistosome infection | |
TW200618812A (en) | Compositions containing piperacillin and tazobactam useful for injection | |
UA6910U (en) | Method for treating acute enteric infections in children | |
TH91790A (th) | วัคซีนรวม ซึ่งประกอบด้วยไวรัสก่อการท้องเสียของสัตว์จำพวกวัว ที่ถูกทำให้อ่อนกำลังลง | |
TH77205B (th) | วัคซีนรวม ซึ่งประกอบด้วยไวรัสก่อการท้องเสียของสัตว์จำพวกวัว ที่ถูกทำให้อ่อนกำลังลง |